India's Serum Institute seeks approval to conduct local trial for Novavax COVID-19 vaccine

Novavax's UK trial, which enrolled 15,000 people aged 18 to 84, is expected to be used to apply for use in Britain, the European Union and other countries.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/39qqOnV
via IFTTT